Notizia - Recent Pharma, Healthcare and Biotech Happenings

GSK to spend USD 100 M to boost its vaccine production Drug maker GlaxoSmithKline has announced to invest USD100 million in its vaccine production site in Montana-one of its nine manufacturing units in the USA. In order to cope with the supply issues GSK faced last year, the company wishes to boost its vaccine production including Shingrix. It is the only vaccine proven to be up to 90% effective at preventing shingles (herpes zoster) in clinical trials. Eli Lilly agrees to sell its legacy antibiotics, a manufacturing plant in China Eli Lilly has announced to sell its antibiotic medicines, Ceclor and Vancocin, and a Ceclor producing manufacturing company in C...